FDA denies marketing application for menthol e-cigarettes

Quitting smoking after a cancer diagnosis improves survival

Quitting smoking within six months after a cancer diagnosis adds an average of two years to a patient’s life, according to a study published inJAMA Oncology, With this information in hand, all cancer centers have an obligation to offer evidence-based smoking cessation to all patients, said Graham Warren, vice-chair for Research in the Department of...

November 08, 2024

Vol.50 No.42

Drugs & Targets

FDA approves MI Cancer Seek as a CDx test for adults and pediatric patients

FDA has approved MI Cancer Seek for use as a companion diagnostic to identify patients with cancer who may benefit from treatment with targeted therapies.

November 08, 2024

Vol.50 No.42

Regulatory News

At his 25-year “anniversary party,” Pazdur invites Califf and past FDA commissioners to talk about political interference

FDA’s cancer czar Richard Pazdur had a “silver anniversary” at the agency recently. So, he invited some guests—the commissioners he had reported to under the Democratic and Republican administrations.

November 01, 2024

Vol.50 No.41

By Claire Marie Porter

Drugs & Targets

FDA approves Scemblix for newly diagnosed CML patients

Scemblix (asciminib) was granted accelerated approval by FDA for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.

November 01, 2024

Vol.50 No.41

In the Archives

New exhibit: Presidential elections and tobacco

In a new online exhibition, The University of Alabama Center for the Study of Tobacco and Society spotlights tobacco advertisements and promotional artifacts from presidential election campaigns.

October 25, 2024

Vol.50 No.40

In Brief

FDA, CBP seize $76M in illegal e-cigarettes

FDA in collaboration with U.S. Customs and Border Protection, announced the administrative seizure of approximately three million units of unauthorized e-cigarette products, with an estimated retail value of $76 million.

October 25, 2024

Vol.50 No.40

FDA denies marketing application for menthol e-cigarettes

YOU MAY BE INTERESTED IN

Quitting smoking after a cancer diagnosis improves survival

FDA approves MI Cancer Seek as a CDx test for adults and pediatric patients

At his 25-year “anniversary party,” Pazdur invites Califf and past FDA commissioners to talk about political interference

FDA approves Scemblix for newly diagnosed CML patients

New exhibit: Presidential elections and tobacco

FDA, CBP seize $76M in illegal e-cigarettes

Renew today!

Subscriber content

Login